Full text

Turn on search term navigation

© 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Pivotal articles that had been published between 2022 and 2023 on surgical and perioperative adjuvant treatments for locally advanced colorectal cancer (CRC) were reviewed. This review focuses on new evidence in the following areas: optimization of surgical procedures for colon cancer, including the optimal length of bowel resection and use of the no‐touch isolation technique; minimally invasive surgery for rectal cancer, such as laparoscopic transanal total mesorectal excision and robotic surgery; neoadjuvant treatments for rectal cancer, including total neoadjuvant therapy; neoadjuvant chemotherapy for colon cancer; and postoperative adjuvant chemotherapy for Stage II and III colon cancer. Although the current understanding may not enable perfect decision‐making for patients and medical professionals, ongoing advancements are expected to result in more effective personalized treatment plans, ultimately improving the prognosis and quality of life of patients.

Details

Title
Essential updates 2022–2023: Surgical and adjuvant therapies for locally advanced colorectal cancer
Author
Kajiwara, Yoshiki 1   VIAFID ORCID Logo  ; Ueno, Hideki 1   VIAFID ORCID Logo 

 Department of Surgery, National Defense Medical College, Tokorozawa, Japan 
Pages
977-986
Section
REVIEW ARTICLE
Publication year
2024
Publication date
Nov 1, 2024
Publisher
John Wiley & Sons, Inc.
e-ISSN
24750328
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3123658327
Copyright
© 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.